GeneDx Holdings (WGS) Price to FCF (2020 - 2026)

GeneDx Holdings (WGS) has reported Price to FCF for 7 consecutive years, with 52.33 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to FCF fell 115.9% year-over-year to 52.33 in Q2 2026; TTM through Jun 2026 was 26.99, a 100.85% decrease from a year earlier, with the FY2025 full-year figure at 266.7, up 520.94% from the prior year.
• Price to FCF was 52.33 for Q2 2026 at GeneDx Holdings, down from 49.03 in the prior quarter.
• Over five years, Price to FCF peaked at 623.47 in Q1 2025 and troughed at 511.45 in Q4 2025.
• A 5-year average of 23.21 and a median of 17.72 in 2022 frame the typical range for Price to FCF.
• Across the five-year window, Price to FCF slumped 15927.3% in 2024 and jumped 4506.45% in 2025, its largest moves.
• Over 5 years, Price to FCF stood at 8.85 in 2022, then surged by 74.97% to 2.22 in 2023, then tumbled by 15927.3% to 355.22 in 2024, then tumbled by 43.98% to 511.45 in 2025, then jumped by 89.77% to 52.33 in 2026.
• The last three Price to FCF figures came in at 52.33 (Q2 2026), 49.03 (Q1 2026), and 511.45 (Q4 2025), per Business Quant data.